The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
NCT ID: NCT04124302
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
76 participants
INTERVENTIONAL
2019-10-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
NCT01678235
Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
NCT02685449
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
NCT04019821
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
NCT04783376
Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump
NCT02546401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IPF
Total meal bolus will consist of insulin for carbohydrates (IC) and insulin for proteins and fats (IPF) based on individual insulin-to-carbohydrate ratio (ICR). Dual bolus will be given 15 minutes before the mixed meal (toast with cheese).
Insulin Glulisine
A kind of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.
Insulin Aspart
A kind of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.
Insulin Lispro
A kind of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.
30%IC
Total meal bolus will consist of insulin for carbohydrates (IC) calculated based on individual insulin-to-carbohydrate ratio (ICR) and insulin for proteins and fats (IPF) estimated as 30% of IC. Dual bolus will be given 15 minutes before the mixed meal (toast with cheese).
Insulin Glulisine
A kind of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.
Insulin Aspart
A kind of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.
Insulin Lispro
A kind of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulin Glulisine
A kind of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.
Insulin Aspart
A kind of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.
Insulin Lispro
A kind of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* insulin pump therapy longer than 3 months
* treated by the same type of insulin longer than 3 months
* written informed consent by patients and parents
Exclusion Criteria
* diabetes related complications (e.g. nephropathy)
* any disease judged by the investigator to affect the trial
* withdrawal of consent to participate in the study
10 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Warsaw Medical University
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mixed Meal Bolus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.